Abstract
The zinc finger protein A20 is encoded by an immediate early response gene and acts as an inhibitor of nuclear factor (NF)-kappaB-dependent gene expression induced by different stimuli, including tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta). Toll-like receptor 2 (TLR2) and TLR4 have been found to transduce, respectively, peptidoglycan (PGN) and lipopolysaccharide (LPS) signals for the activation of NF-kappaB and the production of inflammatory cytokines. Here, we have examined the role of A20 in TLR-mediated NF-kappaB-dependent gene expression in human airway epithelial cells (AECs). Stimulation with LPS and PGN resulted in a significant increase in the level of A20 mRNA in primary cultured AECs and in NCI-H292 AECs. LPS and PGN induced activation of the IL-8 promoter both in NCI-H292 AECs and in HEK293 cells expressing either TLR2 or TLR4 plus MD-2. Dominant-negative myeloid differentiation protein and a mutant form of IkappaBalpha attenuated this PGN- or LPS-induced activation of the IL-8 promoter. Furthermore, overexpression of A20 inhibited activation of both NF-kappaB and the IL-8 promoter by PGN or LPS in these cells. Taken together, our results suggest that A20 may function as a negative regulator of TLR-mediated inflammatory responses in the airway, thereby protecting the host against harmful overresponses to pathogens.
MeSH terms
-
Antigens, Surface / genetics
-
Cell Line
-
DNA-Binding Proteins
-
Humans
-
I-kappa B Proteins / drug effects
-
I-kappa B Proteins / metabolism
-
Inflammation / genetics
-
Inflammation / immunology
-
Inflammation / metabolism
-
Interleukin-8 / biosynthesis*
-
Interleukin-8 / genetics
-
Intracellular Signaling Peptides and Proteins
-
Lipopolysaccharides / pharmacology
-
Lymphocyte Antigen 96
-
Membrane Glycoproteins / drug effects
-
Membrane Glycoproteins / metabolism*
-
NF-KappaB Inhibitor alpha
-
NF-kappa B / drug effects
-
NF-kappa B / metabolism
-
Nuclear Proteins
-
Peptidoglycan / pharmacology
-
Promoter Regions, Genetic / drug effects
-
Promoter Regions, Genetic / genetics
-
Proteins / genetics
-
Proteins / physiology*
-
RNA, Messenger / drug effects
-
RNA, Messenger / metabolism
-
Receptors, Cell Surface / drug effects
-
Receptors, Cell Surface / metabolism*
-
Respiratory Mucosa / drug effects
-
Respiratory Mucosa / immunology*
-
Respiratory Mucosa / metabolism*
-
Toll-Like Receptor 2
-
Toll-Like Receptor 4
-
Toll-Like Receptors
-
Tumor Necrosis Factor alpha-Induced Protein 3
Substances
-
Antigens, Surface
-
DNA-Binding Proteins
-
I-kappa B Proteins
-
Interleukin-8
-
Intracellular Signaling Peptides and Proteins
-
LY96 protein, human
-
Lipopolysaccharides
-
Lymphocyte Antigen 96
-
Membrane Glycoproteins
-
NF-kappa B
-
NFKBIA protein, human
-
Nuclear Proteins
-
Peptidoglycan
-
Proteins
-
RNA, Messenger
-
Receptors, Cell Surface
-
TLR2 protein, human
-
TLR4 protein, human
-
Toll-Like Receptor 2
-
Toll-Like Receptor 4
-
Toll-Like Receptors
-
NF-KappaB Inhibitor alpha
-
TNFAIP3 protein, human
-
Tumor Necrosis Factor alpha-Induced Protein 3